These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 7786438

  • 1. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH, Kim DH, Lee JS, Suh CW, Kim SW, Kim SB, Lee JH, Doh BS, Chi HS, Lee MS.
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [Abstract] [Full Text] [Related]

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Dec; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 3. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M, López Fernández MF, Batlle J.
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [Abstract] [Full Text] [Related]

  • 4. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H, Zhu CY, Wang QS, Niu JH, Zhang Q, Zhu HY, Yao ZL, Xu YY, Jing Y, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [Abstract] [Full Text] [Related]

  • 5. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
    Bassan R, Battista R, Viero P, d'Emilio A, Buelli M, Montaldi A, Rambaldi A, Tremul L, Dini E, Barbui T.
    Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
    [Abstract] [Full Text] [Related]

  • 6. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
    Liang JY, Wu DP, Liu YJ, Ma QF, Xue YQ, Zhu MQ, Chen ZX.
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
    [Abstract] [Full Text] [Related]

  • 7. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
    Koh Y, Park J, Ahn KS, Kim I, Bang SM, Lee JH, Yoon SS, Soon Lee D, Yiul Lee Y, Park S, Kim BK.
    Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
    [Abstract] [Full Text] [Related]

  • 8. Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience.
    Pagnano KB, Traina F, Takahashi T, Oliveira GB, Rossini MS, Lorand-Metze I, Vigorito AC, Miranda EC, De Souza CA.
    Sao Paulo Med J; 2000 Nov 09; 118(6):173-8. PubMed ID: 11120548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA, Rose AB, Felice MS, Alfaro E, Delfino S, Cygler AM, Sackmann-Muriel F.
    Pediatr Hematol Oncol; 2000 Mar 09; 17(2):155-62. PubMed ID: 10734658
    [Abstract] [Full Text] [Related]

  • 11. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
    Ventura GJ, Hester JP, Dixon DO, Khorana S, Keating MJ.
    Hematol Pathol; 1989 Mar 09; 3(1):23-8. PubMed ID: 2745357
    [Abstract] [Full Text] [Related]

  • 12. Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
    Pollicardo N, O'Brien S, Estey EH, al-Bitar M, Pierce S, Keating M, Kantarjian HM.
    Leukemia; 1996 Jan 09; 10(1):27-31. PubMed ID: 8558933
    [Abstract] [Full Text] [Related]

  • 13. Clinical features and treatment outcomes of pediatric acute promyelocytic leukemia in a Mexican pediatric hospital.
    Dorantes-Acosta E, Medina-Sanson A, Jaimes-García Y, López-Martínez B.
    Rev Invest Clin; 2013 Jan 09; 65(5):392-8. PubMed ID: 24687338
    [Abstract] [Full Text] [Related]

  • 14. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C, Lunghi M, Corso A, Tajana M, Zappasodi P, Dabusti M, Lazzarino M, Bernasconi C.
    Haematologica; 1998 Aug 09; 83(8):714-7. PubMed ID: 9793255
    [Abstract] [Full Text] [Related]

  • 15. Acute promyelocytic leukemia, centre, experience, Turkey.
    Yildirim R, Gundogdu M, Ozbıcer A, Kiki I, Erdem F, Dogan H.
    Transfus Apher Sci; 2013 Feb 09; 48(1):45-9. PubMed ID: 22892289
    [Abstract] [Full Text] [Related]

  • 16. HLA-DR antigen-negative acute myeloid leukemia.
    Wetzler M, McElwain BK, Stewart CC, Blumenson L, Mortazavi A, Ford LA, Slack JL, Barcos M, Ferrone S, Baer MR.
    Leukemia; 2003 Apr 09; 17(4):707-15. PubMed ID: 12682628
    [Abstract] [Full Text] [Related]

  • 17. A complete remission can be achieved despite persistence of abnormal bone marrow promyelocytes in acute promyelocytic leukemia--experience in 2 patients.
    Kim SW, Lee KH, Lee JS, Suh C, Ahn MJ, Kim SW, Chi HS, Kim SH.
    J Korean Med Sci; 1993 Aug 09; 8(4):246-50. PubMed ID: 8198760
    [Abstract] [Full Text] [Related]

  • 18. Treatment of patients with acute promyelocytic leukemia. The EORTC-LCG experience. EORTC Leukemia Cooperative Group.
    Willemze R, Suciu S, Mandelli F, de Witte T, Cadiou M, Castoldi GL, Liso V, Dardenne M, Solbu G, Zittoun R.
    Leukemia; 1994 Aug 09; 8 Suppl 2():S48-55. PubMed ID: 7815837
    [Abstract] [Full Text] [Related]

  • 19. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I, Rigal-Huguet F, Vekhoff A, Desablens B, Bordessoule D, Mounier C, Ferrant A, Sanz M, Fey M, Chomienne C, Chevret S, Degos L, Fenaux P, European APL group experience.
    Leukemia; 2003 Aug 09; 17(8):1600-4. PubMed ID: 12886249
    [Abstract] [Full Text] [Related]

  • 20. Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group.
    Haferlach T, Gassmann W, Löffler H, Jürgensen C, Noak J, Ludwig WD, Thiel E, Haase D, Fonatsch C, Becher R.
    Ann Hematol; 1993 Apr 09; 66(4):165-70. PubMed ID: 8485203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.